source name	characteristics[organism]	characteristics[organism part]	characteristics[age]	characteristics[subtype]	characteristics[developmental stage]	characteristics[cell line]	characteristics[cell type]	characteristics[sex]	characteristics[Group]	characteristics[disease]	characteristics[mass]	characteristics[biological replicate]	Material Type	assay name	technology type	comment[data file]	comment[file uri]	comment[technical replicate]	comment[fraction identifier]	comment[label]	comment[dissociation method]	comment[collosion energy]	comment[instrument]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[cleavage agent details]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	factor value[subtype]
PXD028251-sample-4	homo sapiens	plasma	45Y	HER2 Positive Breast Carcinoma	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	1	organism part	run 4	proteomic profiling by mass spectrometry	20200710_BC_04.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_04.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	HER2
PXD028251-sample-14	homo sapiens	plasma	59Y	HER2 Positive Breast Carcinoma	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	2	organism part	run 14	proteomic profiling by mass spectrometry	20200710_BC_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_28.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	HER2
PXD028251-sample-19	homo sapiens	plasma	46Y	HER2 Positive Breast Carcinoma	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	3	organism part	run 19	proteomic profiling by mass spectrometry	20200710_BC_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_36.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	HER2
PXD028251-sample-37	homo sapiens	plasma	49Y	HER2 Positive Breast Carcinoma	not available	not applicable	not available	not available	PCR	breast cancer	not applicable	4	organism part	run 37	proteomic profiling by mass spectrometry	20200727_BC_07.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200727_BC_07.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	HER2
PXD028251-sample-50	homo sapiens	plasma	46Y	HER2 Positive Breast Carcinoma	not available	not applicable	not available	not available	PCR	breast cancer	not applicable	5	organism part	run 50	proteomic profiling by mass spectrometry	20200727_BC_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200727_BC_41.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	HER2
PXD028251-sample-1	homo sapiens	plasma	43Y	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	1	organism part	run 1	proteomic profiling by mass spectrometry	20200710_BC_01.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_01.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma
PXD028251-sample-6	homo sapiens	plasma	58Y	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	2	organism part	run 6	proteomic profiling by mass spectrometry	20200710_BC_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_10.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma
PXD028251-sample-7	homo sapiens	plasma	49Y	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	3	organism part	run 7	proteomic profiling by mass spectrometry	20200710_BC_13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_13.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma
PXD028251-sample-8	homo sapiens	plasma	45Y	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	4	organism part	run 8	proteomic profiling by mass spectrometry	20200710_BC_16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_16.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma
PXD028251-sample-11	homo sapiens	plasma	41Y	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	5	organism part	run 11	proteomic profiling by mass spectrometry	20200710_BC_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_22.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma
PXD028251-sample-12	homo sapiens	plasma	47Y	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	6	organism part	run 12	proteomic profiling by mass spectrometry	20200710_BC_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_26.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma
PXD028251-sample-15	homo sapiens	plasma	45Y	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	7	organism part	run 15	proteomic profiling by mass spectrometry	20200710_BC_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_31.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma
PXD028251-sample-16	homo sapiens	plasma	47Y	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	8	organism part	run 16	proteomic profiling by mass spectrometry	20200710_BC_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_32.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma
PXD028251-sample-17	homo sapiens	plasma	32Y	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	9	organism part	run 17	proteomic profiling by mass spectrometry	20200710_BC_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_33.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma
PXD028251-sample-21	homo sapiens	plasma	42Y	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	10	organism part	run 21	proteomic profiling by mass spectrometry	20200710_BC_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_38.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma
PXD028251-sample-22	homo sapiens	plasma	57Y	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	11	organism part	run 22	proteomic profiling by mass spectrometry	20200710_BC_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_39.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma
PXD028251-sample-24	homo sapiens	plasma	45Y	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	12	organism part	run 24	proteomic profiling by mass spectrometry	20200710_BC_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_43.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma
PXD028251-sample-26	homo sapiens	plasma	44Y	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	13	organism part	run 26	proteomic profiling by mass spectrometry	20200710_BC_47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_47.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma
PXD028251-sample-28	homo sapiens	plasma	43Y	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	14	organism part	run 28	proteomic profiling by mass spectrometry	20200710_BC_49.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_49.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma
PXD028251-sample-29	homo sapiens	plasma	40Y	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	15	organism part	run 29	proteomic profiling by mass spectrometry	20200710_BC_51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_51.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma
PXD028251-sample-31	homo sapiens	plasma	47Y	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	16	organism part	run 31	proteomic profiling by mass spectrometry	20200710_BC_53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_53.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma
PXD028251-sample-33	homo sapiens	plasma	47Y	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	17	organism part	run 33	proteomic profiling by mass spectrometry	20200710_BC_55.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_55.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma
PXD028251-sample-36	homo sapiens	plasma	37Y	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	18	organism part	run 36	proteomic profiling by mass spectrometry	20200710_BC_59.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_59.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma
PXD028251-sample-40	homo sapiens	plasma	37Y	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma	not available	not applicable	not available	not available	PCR	breast cancer	not applicable	19	organism part	run 40	proteomic profiling by mass spectrometry	20200727_BC_15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200727_BC_15.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma
PXD028251-sample-43	homo sapiens	plasma	40Y	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma	not available	not applicable	not available	not available	PCR	breast cancer	not applicable	20	organism part	run 43	proteomic profiling by mass spectrometry	20200727_BC_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200727_BC_20.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	hormone receptor-positive breast cancer/HER2 Negative Breast Carcinoma
PXD028251-sample-20	homo sapiens	plasma	42Y	hormone receptor-positive breast cancer/HER2 Positive Breast Carcinoma	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	1	organism part	run 20	proteomic profiling by mass spectrometry	20200710_BC_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_37.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	hormone receptor-positive breast cancer/HER2 Positive Breast Carcinoma
PXD028251-sample-27	homo sapiens	plasma	49Y	hormone receptor-positive breast cancer/HER2 Positive Breast Carcinoma	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	2	organism part	run 27	proteomic profiling by mass spectrometry	20200710_BC_48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_48.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	hormone receptor-positive breast cancer/HER2 Positive Breast Carcinoma
PXD028251-sample-39	homo sapiens	plasma	41Y	hormone receptor-positive breast cancer/HER2 Positive Breast Carcinoma	not available	not applicable	not available	not available	PCR	breast cancer	not applicable	3	organism part	run 39	proteomic profiling by mass spectrometry	20200727_BC_14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200727_BC_14.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	hormone receptor-positive breast cancer/HER2 Positive Breast Carcinoma
PXD028251-sample-46	homo sapiens	plasma	60Y	hormone receptor-positive breast cancer/HER2 Positive Breast Carcinoma	not available	not applicable	not available	not available	PCR	breast cancer	not applicable	4	organism part	run 46	proteomic profiling by mass spectrometry	20200727_BC_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200727_BC_25.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	hormone receptor-positive breast cancer/HER2 Positive Breast Carcinoma
PXD028251-sample-47	homo sapiens	plasma	66Y	hormone receptor-positive breast cancer/HER2 Positive Breast Carcinoma	not available	not applicable	not available	not available	PCR	breast cancer	not applicable	5	organism part	run 47	proteomic profiling by mass spectrometry	20200727_BC_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200727_BC_29.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	hormone receptor-positive breast cancer/HER2 Positive Breast Carcinoma
PXD028251-sample-2	homo sapiens	plasma	50Y	triple-negative breast cancer	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	1	organism part	run 2	proteomic profiling by mass spectrometry	20200710_BC_02.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_02.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	triple-negative breast cancer
PXD028251-sample-3	homo sapiens	plasma	45Y	triple-negative breast cancer	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	2	organism part	run 3	proteomic profiling by mass spectrometry	20200710_BC_03.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_03.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	triple-negative breast cancer
PXD028251-sample-5	homo sapiens	plasma	51Y	triple-negative breast cancer	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	3	organism part	run 5	proteomic profiling by mass spectrometry	20200710_BC_08.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_08.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	triple-negative breast cancer
PXD028251-sample-9	homo sapiens	plasma	48Y	triple-negative breast cancer	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	4	organism part	run 9	proteomic profiling by mass spectrometry	20200710_BC_18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_18.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	triple-negative breast cancer
PXD028251-sample-10	homo sapiens	plasma	35Y	triple-negative breast cancer	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	5	organism part	run 10	proteomic profiling by mass spectrometry	20200710_BC_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_21.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	triple-negative breast cancer
PXD028251-sample-13	homo sapiens	plasma	42Y	triple-negative breast cancer	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	6	organism part	run 13	proteomic profiling by mass spectrometry	20200710_BC_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_27.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	triple-negative breast cancer
PXD028251-sample-18	homo sapiens	plasma	35Y	triple-negative breast cancer	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	7	organism part	run 18	proteomic profiling by mass spectrometry	20200710_BC_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_34.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	triple-negative breast cancer
PXD028251-sample-23	homo sapiens	plasma	42Y	triple-negative breast cancer	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	8	organism part	run 23	proteomic profiling by mass spectrometry	20200710_BC_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_42.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	triple-negative breast cancer
PXD028251-sample-25	homo sapiens	plasma	49Y	triple-negative breast cancer	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	9	organism part	run 25	proteomic profiling by mass spectrometry	20200710_BC_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_46.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	triple-negative breast cancer
PXD028251-sample-30	homo sapiens	plasma	53Y	triple-negative breast cancer	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	10	organism part	run 30	proteomic profiling by mass spectrometry	20200710_BC_52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_52.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	triple-negative breast cancer
PXD028251-sample-32	homo sapiens	plasma	36Y	triple-negative breast cancer	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	11	organism part	run 32	proteomic profiling by mass spectrometry	20200710_BC_54.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_54.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	triple-negative breast cancer
PXD028251-sample-34	homo sapiens	plasma	46Y	triple-negative breast cancer	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	12	organism part	run 34	proteomic profiling by mass spectrometry	20200710_BC_57.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_57.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	triple-negative breast cancer
PXD028251-sample-35	homo sapiens	plasma	51Y	triple-negative breast cancer	not available	not applicable	not available	not available	NPCR	breast cancer	not applicable	13	organism part	run 35	proteomic profiling by mass spectrometry	20200710_BC_58.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200710_BC_58.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	triple-negative breast cancer
PXD028251-sample-38	homo sapiens	plasma	46Y	triple-negative breast cancer	not available	not applicable	not available	not available	PCR	breast cancer	not applicable	14	organism part	run 38	proteomic profiling by mass spectrometry	20200727_BC_12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200727_BC_12.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	triple-negative breast cancer
PXD028251-sample-41	homo sapiens	plasma	37Y	triple-negative breast cancer	not available	not applicable	not available	not available	PCR	breast cancer	not applicable	15	organism part	run 41	proteomic profiling by mass spectrometry	20200727_BC_17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200727_BC_17.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	triple-negative breast cancer
PXD028251-sample-42	homo sapiens	plasma	45Y	triple-negative breast cancer	not available	not applicable	not available	not available	PCR	breast cancer	not applicable	16	organism part	run 42	proteomic profiling by mass spectrometry	20200727_BC_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200727_BC_19.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	triple-negative breast cancer
PXD028251-sample-44	homo sapiens	plasma	49Y	triple-negative breast cancer	not available	not applicable	not available	not available	PCR	breast cancer	not applicable	17	organism part	run 44	proteomic profiling by mass spectrometry	20200727_BC_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200727_BC_23.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	triple-negative breast cancer
PXD028251-sample-45	homo sapiens	plasma	49Y	triple-negative breast cancer	not available	not applicable	not available	not available	PCR	breast cancer	not applicable	18	organism part	run 45	proteomic profiling by mass spectrometry	20200727_BC_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200727_BC_24.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	triple-negative breast cancer
PXD028251-sample-48	homo sapiens	plasma	48Y	triple-negative breast cancer	not available	not applicable	not available	not available	PCR	breast cancer	not applicable	19	organism part	run 48	proteomic profiling by mass spectrometry	20200727_BC_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200727_BC_30.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	triple-negative breast cancer
PXD028251-sample-49	homo sapiens	plasma	46Y	triple-negative breast cancer	not available	not applicable	not available	not available	PCR	breast cancer	not applicable	20	organism part	run 49	proteomic profiling by mass spectrometry	20200727_BC_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200727_BC_35.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	triple-negative breast cancer
PXD028251-sample-51	homo sapiens	plasma	51Y	triple-negative breast cancer	not available	not applicable	not available	not available	PCR	breast cancer	not applicable	21	organism part	run 51	proteomic profiling by mass spectrometry	20200727_BC_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/02/PXD028251/20200727_BC_45.raw	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1000422;NT=HCD	27% NCE	NT=Q Exactive;AC=MS:1001911	NT=Carbamidomethyl;MT=fixed;AC=UNIMOD:4;TA=C	NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable	NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35	AC=MS:1001313;NT=Trypsin	10 ppm	0.02 Da	triple-negative breast cancer
